RVNC INVESTOR ALERT: Kirby McInerney LLP Notifies Revance Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the March 4, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:RVNC) securities during the period from February 29, 2024, through December 6, 2024 (“the Class Period”). [LEARN MORE ABOUT THE CLASS ACTION] Prior to the Class Period, in January 2020, Revance entered in ...